Synthesis of the FSH ␤-subunit (FSH␤) is critical for normal reproduction in mammals, and its expression within the pituitary gonadotrope is tightly regulated by activin. Here we show that Runt-related (RUNX) proteins, transcriptional regulators known to interact with TGF␤ signaling pathways, suppress activin induction of FSH␤ gene expression. Runx2 is expressed within the murine pituitary gland and dramatically represses activin-induced FSH␤ promoter activity, without affecting basal expression in L␤T2 cells, an immortalized mouse gonadotrope cell line. This repressive effect is specific, because RUNX2 induces LH␤ transcription (with or without activin) and does not interfere with GnRH induction of either gonadotropin ␤-subunit gene. Analysis of the murine FSH␤ promoter by transfection and gel shift assays reveals that RUNX2 repression localizes to a Runx-binding element at Ϫ159/Ϫ153, which is adjacent to a previously recognized region critical for activin induction. Mutation of this Ϫ153 activin-response element or, indeed, any of the five activin-responsive regions prevents activin induction and, in fact, RUNX2 suppression, instead converting RUNX2 to an activator of the FSH␤ gene. Although the Runx-binding element is required for RUNX2-mediated repression of FSH␤ induction by either activin or Smad3, confirming a functional role of this novel site, protein interactions in addition to those between RUNX2 and Smads are necessary to account for full repression of activin induction. In summary, the present study provides evidence for Runx2-mediated repression of activin-induced FSH␤ gene expression and reveals the context dependence of Runx2 action in hormonal regulation of the gonadotropin genes. (Endocrinology 151: 2669 -2680, 2010) F SH is essential for reproductive function in mammals. Indeed, female mice lacking FSH are infertile due to defects in proper development and maturation of ovarian follicles (1). At the molecular level, FSH is a heterodimer consisting of a common ␣-subunit complexed with a unique ␤-subunit (2). The ␤-subunit confers biological specificity, and its synthesis is the rate-limiting step in the overall production of FSH (2, 3). Transcriptional regulation of FSH␤ occurs via endocrine, paracrine, and autocrine action from a variety of key players including hypothalamic GnRH, gonadal steroid hormones, and the activin-inhibin-follistatin system (3, 4).
F
SH is essential for reproductive function in mammals. Indeed, female mice lacking FSH are infertile due to defects in proper development and maturation of ovarian follicles (1) . At the molecular level, FSH is a heterodimer consisting of a common ␣-subunit complexed with a unique ␤-subunit (2). The ␤-subunit confers biological specificity, and its synthesis is the rate-limiting step in the overall production of FSH (2, 3) . Transcriptional regulation of FSH␤ occurs via endocrine, paracrine, and autocrine action from a variety of key players including hypothalamic GnRH, gonadal steroid hormones, and the activin-inhibin-follistatin system (3, 4) .
Activin, a member of the TGF␤ superfamily, is an important regulator of FSH synthesis and promotes expression of FSH␤ during the ovulatory cycle (5, 6) . The activity of activin is antagonized by a closely related TGF␤ family member, inhibin, and both are critical for physiological regulation of FSH synthesis. Mice lacking either activin or inhibin exhibit abnormal FSH␤ expression and disrupted fertility (6, 7) , demonstrating the importance of their transcriptional regulation of FSH␤ for overall reproductive fitness.
Although activin is considered an important regulator of FSH␤-subunit gene expression, the mechanisms underlying transcriptional responsiveness are complex, requiring many individual elements that act in cooperation, and exhibit species specificity (8 -11) . Several of these activin response elements have been found to harbor consensus Smad-binding sites, and a few of these sites have been shown to bind Smad proteins, known mediators of TGF␤ signaling cascades, including activin (8, 11, 12) . Of interest, the Ϫ153 activin-response element in the mouse (Ϫ167 in the ovine gene) is required to respond effectively to activin (8, 11) but has not been shown to directly bind Smad proteins or any other known activin-induced mediator. Interestingly, Su et al. (13) demonstrated that disruption of a sequence juxtaposed to this activin-responsive site within the context of the ovine FSH␤ promoter causes severe dysregulation of basal expression and transcriptional regulation in L␤T2 cells. When this mutant ovine FSH␤ reporter was introduced into transgenic mice, the transgene revealed diminished basal expression, improper regulation by activin or follistatin, and failure to exhibit the secondary FSH surge (13) . In silico analysis indicated that this sequence could represent a putative binding site for the runt-related (RUNX) family of transcription factors.
The RUNX family of nuclear transcription factors (RUNX, human; Runx, mouse) was originally identified in Drosophila as the pair rule gene runt (14) . In mammals, the three Runx family members (Runx1, -2, and -3) all play critical roles in cell differentiation, tissue development, and ultimately, human disease (15) . The gene-regulatory actions of Runx factors are mediated not only by binding specific promoter regions, using a conserved Runt domain essential for DNA binding but also through the formation of protein interactions that assist in the assembly of transcriptional complexes at specific subnuclear sites (16, 17) . These protein-protein interactions potently influence transactivation or repression by Runx itself and increase the complexity of the mechanisms of transcriptional regulation by Runx family members.
Given that Runx factors appear to function as scaffolding proteins involved in the integration of complex and coordinated gene-regulatory mechanisms, including TGF␤ family signaling, we sought to investigate the role for Runx proteins in the transcriptional regulation of FSH␤. In L␤T2 cells, a model of cultured gonadotrope cells that endogenously expresses FSH␤ and contains the machinery to respond to the activin-follistatin system, RUNX proteins abrogated activin induction of FSH␤ promoter activity. We further identified a Runx cis-regulatory element at Ϫ159 in the murine FSH␤ promoter juxtaposed to the Ϫ153 critical region for activin responsiveness. This Runx-binding site not only is necessary for the physical interaction of Runx2 with the murine FSH␤ promoter. but it is also required for RUNX2 repression of activin induction. These results clarify the importance of Runt-related transcription factors in transcriptional regulation within the gonadotrope cell and provide an important role for Runx2 in feedback control of reproductive hormone synthesis.
Materials and Methods

Plasmids
FSH␤ reporter plasmids have been previously described: Ϫ1000 murine FSH␤luc (18, 19) ; Ϫ985 ovine FSH␤luc (20, 21) ; Ϫ1028 human FSH␤luc (12) ; and the activin-response element cis mutations within the Ϫ1000 murine FSH␤luc at Ϫ267, Ϫ153, Ϫ120, and the 5X mutation (containing mutations in all five activin-responsive elements at Ϫ267, Ϫ153, Ϫ139, Ϫ120, and Ϫ106) (11). The 1.8-kb rat LH␤luc was kindly provided by Mark Lawson. The expression vectors for human RUNX1, -2, and -3 were provided by Yoshiaki Ito (22) , and murine Runx2 was provided by Jane Lian (16, 17) . Smad3 was provided by Rik Derynck (23) .
Mutations were generated by PCR using specific primers (Supplemental Table 1 published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org) for the Ϫ398 FSH␤ promoter (Ϫ156/Ϫ154 mutation) or murine Runx2 expression vector (HTY and WRPY). Mutagenesis was performed using the QuikChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA) and confirmed by sequencing.
Cell culture and transient transfection
L␤T2 cells, cultured as previously described (18) , were seeded into 12-well plates at 3 ϫ 10 5 cells per well and incubated overnight at 37 C. Each well was transfected with 400 ng of the luciferase-reporter plasmid or empty pGL3 vector, 200 ng of the human RUNX1, -2, or -3 expression vector (vector pEF-BOS), murine Runx2 (vector pHA) or empty vector, and 100 ng of a ␤-galactosidase reporter gene regulated by the thymidine kinase promoter (TK-␤gal) as a control for transfection efficiency using FuGENE 6 transfection reagent (Roche Applied Science, Indianapolis, IN). In experiments using Smad3 to induce FSH␤ promoter activity, cells were also transfected with 200 ng Smad3 or empty pRK5 vector. Eighteen hours after transfection, cells were transferred to serum-free DMEM supplemented with 0.1% BSA, 5 mg/liter transferrin, and 50 nM sodium selenite. After 6 h, activin A (25 ng/ml; Calbiochem, San Diego, CA), follistatin (25 ng/ml; R&D Systems, Minneapolis, MN), or vehicle (0.1% BSA) was administered for 24 h before harvest. Where indicated, GnRH (10 ng/ml; Sigma-Aldrich, St. Louis, MO) treatment began 6 h before harvest. Cells were harvested and extracts prepared for assay of luciferase and ␤-galactosidase activity as previously described (24) .
Quantitative real-time PCR
Preparation of cDNA from mouse pituitary or L␤T2 cells was performed as previously described (25) . Male and female C57BL/6 mice (6 wk of age) were purchased from The Jackson Laboratory (Bar Harbor, ME), and housed in a University of California, San Diego (UCSD), animal facility under standard conditions. At 8 wk of age, mice were decapitated and pituitaries removed for immediate processing. All procedures were approved by the UCSD Institutional Animal Care and Use Committee. Briefly, RNA was extracted with Trizol reagent (Invitrogen/GIBCO, Carlsbad, CA) according to the manufacturer's instructions, treated to remove contaminating DNA (DNA-free; Ambion, Austin, TX), and reverse transcribed using Superscript III first-strand synthesis system (Invitrogen). Quantitative realtime PCR was performed in an iQ5 real-time PCR instrument (Bio-Rad, Hercules, CA) and used iQ SYBR Green Supermix (Bio-Rad) with specific primers for GAPDH, FSH␤, Runx2, and total Runx (Supplemental Table 1 ).
The iQ5 real-time PCR program was as follows: 95 C for 15 min, followed by 40 cycles at 95 C for 15 sec, 55 C for 30 sec, and 72 C for 30 sec. Within each experiment, the amount of FSH␤, Runx2 or total Runx, and GAPDH was calculated by comparing a threshold cycle obtained for each sample with the standard curve generated from serial dilutions of a plasmid containing GAPDH, ranging from 1 ng to 1 fg. Values for FSH␤ and Runx2 or total Runx were determined from the same sample and are expressed relative to GAPDH. All samples were assayed (in triplicate) within the same run, and the experiment was conducted two times.
Western blotting analysis
Nuclear extracts were prepared from ␣T3-1 and L␤T2 cells as previously described (26) . When experiments were conducted with activin A (25 ng/ml), follistatin (25 ng/ml), or vehicle (0.1% BSA), treatment began 24 h before harvest. Nuclear extract (30 g) was boiled for 5 min in 5ϫ Western loading buffer, fractionated on a 10% SDS-PAGE gel, and electroblotted for 90 min at 300 mA onto polyvinylidene difluoride (Millipore, Billerica, MA) in 1ϫ Tris-glycine-sodium dodecyl sulfate/20% methanol. Blots were blocked overnight at 4 C in 3% BSA and then probed for 1 h at room temperature with goat antihuman Runx1, rabbit antimouse Runx2, or rabbit antihuman Runx3 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:500 in blocking buffer. Blots were then incubated with a horseradish peroxidaselinked secondary antibody (Santa Cruz Biotechnology) and bands visualized using the SuperSignal West Pico chemiluminescent substrate (Pierce Biotechnology Inc., Rockford, IL). BioRad prestained protein ladder plus serves as a size marker.
EMSA
Mouse FSH␤ promoter oligonucleotides from Ϫ164 to Ϫ134 (Supplemental Table 1 ) or the corresponding sequences in the sheep and human were annealed, end-labeled, and purified as previously described (27) . Binding reactions used 2 fmol 32 Plabeled oligonucleotide and 8 g L␤T2 nuclear extract. In competitor assays, 250-fold excess unlabeled oligonucleotide was added to the binding reaction before addition of probe. For supershift assays, 1 g rabbit antimouse Runx2 antibody (Santa Cruz Biotechnology) or normal rabbit IgG control, was added to the reaction. Reactions were electrophoresed on a 5% polyacrylamide gel at 250 V for 2 h and then dried under vacuum and exposed to film.
Statistics
All experiments were performed in triplicate and were repeated at least three times. To normalize for transfection efficiency, all luciferase values were divided by ␤-galactosidase, and the triplicate values were averaged. To control for interexperimental variation, the empty pGL3 reporter plasmid was transfected with TK-␤gal and any relevant expression vectors, and the average pGL3/␤gal value was calculated. Average luc/␤gal values were divided by the corresponding pGL3/␤gal value. Individual values obtained from each independent experiment were then averaged, and statistics were performed using JMP 7.0 (SAS, Cary, NC). Significance was established as P Ͻ 0.05 by two-way ANOVA followed by Tukey's post hoc test. nuclear extracts from both L␤T2 cells and ␣T3-1 cells, a gonadotrope precursor cell line (Fig. 1B) , revealing a cell model for understanding the role of this novel family of transcription factors in gonadotrope subunit gene expression.
Results
RUNX
RUNX proteins regulate FSH␤ gene expression in gonadotrope cells
Because activin is a potent regulator of FSH␤ synthesis, we sought to test whether Runx proteins are transcriptional effectors of FSH␤. The murine FSH␤ promoter (Ϫ1000 bp) fused upstream of a luciferase reporter gene (FSH␤luc) was transiently cotransfected along with human RUNX1, -2, or -3 expression vectors into L␤T2 cells. Overexpression of RUNX1, -2, or -3 did not significantly alter basal expression of the 1-kb murine FSH␤ promoter ( Fig. 2A) . In contrast, all three RUNX proteins blunted the robust induction by activin (Fig. 2B) . Specifically, treatment with activin resulted in an 11-fold induction of FSH␤, which was reduced by 42, 48, or 23%, byRUNX1, RUNX2, or RUNX3, respectively. Although all three mammalian Runx proteins are present in L␤T2 cells and are capable of transcriptional repression of activin induction of the FSH␤ promoter, we focused on Runx2 based on the intensity of its effect and evidence for its interaction with members of TGF␤ signaling cascades (29, 30) . We first confirmed the presence of Runx2 within the murine pituitary gland (Fig. 2C ) and determined whether protein expression is changed by treatment with activin or follistatin ( Fig. 2D ), a potent activin-binding protein that neutralizes endogenous activin secreted by the L␤T2 cell itself (31) . Levels of Runx2 protein are similar in L␤T2 cells treated with vehicle, activin, and follistatin. Collectively, these data identify the Runx family as potential regulators of gonadotrope function and focus our attention on the molecular mechanism whereby RUNX2 potently represses FSH␤ expression.
Differential regulation of FSH␤ and LH␤ by RUNX2
Appropriate expression of the gonadotropin subunit genes is dependent on paracrine and autocrine actions within the anterior pituitary. To determine whether the effect of RUNX2 is dependent on hormonal milieu, L␤T2 cells were cultured in the presence of activin, follistatin, or GnRH, and the effect of RUNX2 overexpression was assessed on FSH␤ promoter activity. Again, RUNX2 potently reduced activin-induced FSH␤ expression (Fig. 3A) , whereas it failed to alter FSH␤ promoter activity in cells treated with follistatin, indicating that RUNX2 repression requires a threshold level of promoter activation. Moreover, this effect does not occur with any hormonal induction because GnRH regulation, although it results in a 2.7-fold induction of FSH␤ expression, is not affected by RUNX2, indicating that repression by RUNX2 is specific for induction by activin.
Previously, we reported that, in addition to its affect on FSH␤, activin signaling induces LH␤ expression, albeit to a lesser extent (32) . To further address the specificity of RUNX2 action on gonadotropin subunit gene expression, we tested the effect of RUNX2 on LH␤ promoter activity. RUNX2 was transiently cotransfected along with Ϫ1800 bp of the rat LH␤ promoter fused to a luciferase reporter (LH␤luc) into L␤T2 cells. Upon treatment with activin alone, LH␤ expression was induced 1.6-fold, whereas vehicle empty vector control; *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001, significant suppression by RUNX expression plasmid vs. empty vector expression plasmid in the presence of activin as determined by two-way ANOVA followed by Tukey's post hoc test. C, Quantitative RT-PCR analysis of Runx2 and FSH␤ mRNA extracted from male and female mouse pituitary (pit) tissue or L␤T2 cells. D, Western blotting analysis of Runx2 in nuclear extracts from L␤T2 cells treated with activin, follistatin, or vehicle (control), using an antibody specific for Runx2 (Ab: ␣-Runx2). The experiment was repeated three times with similar results, and a representative gel is shown.
GnRH induced LH␤ by 2.0-fold (Fig. 3B) . In contrast to its effect on FSH␤, RUNX2 induced LH␤ expression nearly 2-fold, and this increase occurred in the presence of vehicle, activin, or follistatin. Interestingly, RUNX2 does not appear to further induce LH␤ in the presence of GnRH. Taken together, these experiments demonstrate that the repressive action of RUNX2 is specific to FSH␤ and dependent on elevated levels of circulating activin.
RUNX2 repression localizes to an activin-responsive region of the FSH␤ promoter
We examined the proximal promoter region of the murine FSH␤ gene and identified three possible binding sites for Runx transcription factors within 1 kb upstream of the transcription start site [Ϫ652, Ϫ455, and Ϫ159; Ͼ85% identity each, by web-based software TFSEARCH (33) ]. To identify regions of the FSH␤ gene that are functionally involved in RUNX2 regulation, L␤T2 cells were transiently transfected with a series of truncated FSH␤ reporter plasmids, ranging in length from Ϫ1000 to Ϫ95 bp of the 5Ј regulatory sequence. Figure 4 illustrates the effects of cotransfection of RUNX2 on the progressive 5Ј-promoter truncations on basal (Fig. 4A) or activin-induced FSH␤ promoter activity (Fig. 4B) . Although RUNX2 causes no change in basal expression of the 1-kb FSH␤ promoter (Fig. 4A,  Ϫ1000) , expression is increased by approximately 30% when the reporter gene is truncated to Ϫ230 or Ϫ194. Further deletion of the region to Ϫ127 results in a loss of RUNX2 induction, indicating that elements important for the effect of RUNX2 on basal FSH␤ expression reside within the Ϫ194-to Ϫ127-bp region of the gene.
As observed previously (25) , activin induction of the FSH␤ gene declined incrementally as the promoter was progressively truncated from Ϫ1000 to Ϫ95 (Fig. 4B) . RUNX2 repressed FSH␤ promoter activity by approximately 40% when the region contained at least Ϫ304 bp of the proximal promoter. Interestingly, further truncation of the region from Ϫ304 to Ϫ230, removing the most 5Ј activin response element at Ϫ267 (34), results in a loss of activin induction and elimination of RUNX2 repression, indicating that activin responsiveness of the FSH␤ gene is required for RUNX2 repression.
The Ϫ267 site is one of five important cis-regulatory elements (Fig. 4C) , each of which is critical for activin responsiveness of the murine FSH␤ gene (8, 11, 34) . These bind proteins such as Smad family members (11, 34) , Pbx1 and Prep1 homeodomain proteins (8, 11) , or forkhead transcription factor L2 (FoxL2) (35) . We therefore analyzed the necessity of the known activin response elements within the FSH␤ gene for RUNX2 repression (11) . Remarkably, cis mutation of individual elements or combined mutation of all five sites in the 1-kb FSH␤ promoter allowed RUNX2 to induce expression in the absence of activin (Fig. 4D) , similar to its effect on basal expression of the promoter truncations (Ϫ230 and Ϫ194; Fig. 4A ). As in the case of the Ϫ230 truncation that lost activin responsiveness concurrent with RUNX2 repression, mutation of single elements in the FSH␤ gene prevents activin induction and, thus, RUNX2 repression in the presence of activin (Fig. 4E) . In fact, mutation of all five activin response elements actually converts the repression by RUNX2 to strong induction. Taken together, these data indicate that the direction of RUNX2 activation or repression is dependent on representation, availability, and coordinated binding of coregulatory factors, including those involved in activin signaling.
Runx2 binds a novel Runx element within the FSH␤ proximal promoter
Because we found that each mutation or truncation that prevents activin induction also prevents RUNX2 repression, we focused on the region of the FSH␤ gene required for RUNX2 activation in the absence of activin. In silico analysis of this region (Ϫ194/Ϫ127) identified a putative Runx-binding site based on homology to a consensus recognition sequence 5Ј-PyGPyGGTPy-3Ј (36). This putative site, Ϫ159 TGTGGCA Ϫ153, is positioned immediately upstream of the activin response element at Ϫ153 ATT-TAGAC Ϫ146 (Fig. 4C ). EMSAs were performed to test the hypothesis that Runx2 could physically interact at this site. When an oligonucleotide encompassing the Ϫ164/ Ϫ134 region of the gene was used in EMSA with nuclear extracts from L␤T2 cells, specific complexes were observed (Fig. 5A, We next determined the nucleotides necessary for Runx2 interaction with DNA. EMSA was performed with the wild-type Ϫ164/Ϫ134 probe (Fig. 5B, WT) and scanning 2-bp mutant oligonucleotides as unlabeled competitors (Fig. 5B, A-M) . The three mutant oligonucleotides that were unable to compete for Runx2 binding, mutations C-E (Fig. 5C, lanes 5-7) , together encompass six of the seven nucleotides within the putative Runx site identified at Ϫ159/Ϫ153.
RUNX2 repression is conserved across species
Elements conveying responsiveness to activin are well conserved across species, and a recent report (13) , combined with the current study, implicates the Runx family of transcription factors in the regulation of activin responsiveness in the sheep and mouse. We tested the hypothesis that RUNX regulation is a conserved mechanism of repression among mouse, sheep, and humans by transiently transfecting RUNX2 into L␤T2 cells along with either a Ϫ985 ovine FSH␤luc or Ϫ1028 human FSH␤luc, and compared repression with the Ϫ1000 murine FSH␤luc reporter (Fig. 6, A and B) . The effect of RUNX2 on basal and activin-induced FSH␤ promoter activity is similar for all three species. Specifically, ovine, human, and murine basal FSH␤ promoter activity was not significantly altered by RUNX2 (Fig. 6A) . In contrast, responsiveness to activin was reduced by 53% in the sheep, 39% in the human, and 47% in the mouse (Fig. 6B) , demonstrating that repression by RUNX2 is functionally conserved in the ovine, human and murine FSH␤ genes.
DNA sequences of the ovine and human FSH␤ genes were compared with that of the murine Ϫ159 Runx-binding site (Fig. 6C, murine, underlined) and investigated for conservation. Although this murine Runx site shows minimal conservation (Ͻ50% conserved) with the species investigated, another site was recently reported as critical for activin responsiveness of the ovine FSH␤ gene in vivo and proposed as a putative Runx-binding site based on its sequence (13) . This Runx site sits 3 bp downstream of the , and analyzed for FSH␤ promoter activity as described above. The FSH␤luc reporter plasmids either contained elements mutated individually (Ϫ267 mut, Ϫ153 mut, and Ϫ120 mut) or all five elements mutated in combination (5X mut; containing cis mutations at Ϫ267, Ϫ153, Ϫ139, Ϫ120, and Ϫ106).
murine Ϫ159 Runx site and is highly conserved between human and ovine (Fig. 6C, ovine, dashed underline) , providing circumstantial evidence that the region encompassing the Ϫ153 activin response element (Fig. 6C , illustrated on murine promoter, gray shading) harbors a potential element for Runx modulation of activin responsiveness across multiple species.
EMSA was performed with species-specific oligonucleotide probes corresponding to the Ϫ164/Ϫ134 FSH␤ region of the mouse to determine whether Runx2 binds this region in the ovine and human FSH␤ genes as well. L␤T2 nuclear extracts were incubated with probe alone, nonspecific IgG, or a Runx2-specific antibody (Fig. 6D) . Although an antibody specific for Runx2 causes a supershift on the murine probe ( Fig. 6D; lane 9 , supershifted complex indicated as Runx2 ss), a complex was not detected on the ovine or human probe that could be identified as Runx2 or a supershift of Runx2. It is possible that we could not visualize binding of Runx2 on the sheep and human probes due to lower-affinity binding than the mouse. Altogether, our results identify a conserved mechanism of repression of activin induction via RUNX2 but raise the possibility that RUNX2 uses different sequences from those identified in the mouse to mediate repression of the sheep and human FSH␤ promoters.
Integrity of the Runx-binding element is critical for RUNX2 repression
Once we had determined that Runx2 could bind the Runx element at Ϫ159/Ϫ153, transient transfection assays were used to determine whether this site plays a functional role in the suppression of activin-induced FSH␤ gene expression by RUNX2. For this experiment, L␤T2 cells were transfected with the Ϫ398 FSH␤luc reporter (wild type) or the same reporter plasmid containing a cis mutation in which the Ϫ156 GGC Ϫ154 nucleotides, known to be critical for high-affinity binding by Runx proteins to DNA (37) (Fig. 5C) , were mutated to AAA (Ϫ156/Ϫ154 mutation). Basal FSH␤ promoter activity was slightly, but not significantly, elevated by introduction of the Runx site cis mutation compared with the wildtype mouse FSH␤ promoter (Fig. 7A, WT) ; overexpression of RUNX2 did not alter promoter activity compared with the empty vector control (Fig. 7A , Ϫ156/Ϫ154 mutation). Activin induced FSH␤ expression of both the wildtype and Ϫ156/Ϫ154 mutant FSH␤ promoters equally (Fig. 7B) . Although RUNX2 suppresses activin induction of the wild-type promoter ( Fig. 7B ; WT, ϳ50% reduced by RUNX2), mutation of the Runx element prevents RUNX2 repression of activin-induced FSH␤ expression ( Fig. 7B ; Ϫ156/Ϫ154 mutation, not significantly suppressed as indicated by ns). Mutation of this binding site does not alter the ability of RUNX1 or RUNX3 to repress the induction of FSH␤ (P Ͼ 0.05, data not shown). Taken together, these studies indicate that the Ϫ159 Runx site within the FSH␤ promoter is important and necessary for the suppressive effect of RUNX2.
It is well established that Smad proteins are critical for murine FSH␤ expression (9, 10, 34, 38) . Indeed, mice lacking Smad3 exhibit reduced FSH␤ expression (32), illustrating the importance of this Smad factor in vivo. We hypothesized that if RUNX2 suppresses activin induction via disrupting Smad signaling, then overexpression of RUNX2 would repress the induction of FSH␤ by Smad3. Alternatively, if RUNX2 were acting upstream of Smad3 in the activin signaling cascade, RUNX2 would not interfere with induction by Smad3. As expected, overexpression of Smad3 induces a robust increase in wild-type FSH␤ promoter activity; this response is potently repressed by RUNX2 ( Fig. 7C ; WT, ϳ80% reduced by RUNX2). Similar to the case with activin, RUNX2 is unable to suppress Smad3 induction of the FSH␤ promoter containing the Ϫ156/Ϫ154 mutation ( Fig. 7C ; Ϫ156/Ϫ154 Mutation). Collectively, these data show that the Ϫ159 Runx site is necessary for RUNX2 to inhibit Smad3-induced transcriptional activity and support the hypothesis that RUNX2 repression of FSH␤ expression acts on or downstream of Smad3 activation.
Mutation of the Smad interacting domain of Runx2 fails to relieve Runx2 repression of activin induction
The carboxy terminus of RUNX2 contains specific regions necessary for mediating functional interactions with a number of coregulatory proteins involved in either transcriptional activation or repression (29, 39 -43) . For example, a three-amino-acid His-Thr-Tyr motif (HTY; amino acids 426-428) within the Smad interacting domain of Runx2 has been shown to mediate Smad protein interactions (29, 39) , and a four-amino-acid Trp-Arg-Pro-Tyr motif (WRPY; amino acids 525-528) is necessary for interactions with corepressors of the Groucho/TLE family (40) . We assessed the importance of these motifs for Runx2-induced repression of activin-or Smad3-induced FSH␤ promoter activity by cotransfecting a murine Runx2 plasmid containing either HTY (HTY) or WRPY (WRPY) domain mutations (residues mutated to alanine; AAA or AAAA, respectively). Overexpression of Runx2 or WRPY results in a similar reduction in Smad3-induced FSH␤ activity ( Fig. 8A; Runx2 vs. WRPY) . In contrast, HTY fails to significantly repress FSH␤ expression ( Fig. 8A ; Runx2 vs. HTY, P Ͻ 0.05), suggesting that the Runx2 HTY motif is necessary to mediate repression by Runx2. Interestingly, neither the WRPY nor the HTY Runx2 mutation was sufficient to alleviate repression when FSH␤ was induced by activin ( Fig. 8B ; Runx2 vs. WRPY or HTY, P Ͼ 0.05), although there was a trend for reduced inhibition by HTY (P ϭ 0.08 vs. Runx2). Furthermore, mutation of either domain did not alter the ability of Runx2 to induce LH␤ (Fig. 8C) , suggesting that Runx2 coordinates induction of LH␤ via interaction with proteins other than Smads or Groucho family members. Taken together, these results demonstrate that the Runx2 HTY motif is critical for repression of Smad3-induced FSH␤ activity but not solely responsible for mediating the repressive actions of Runx2 on FSH␤ expression induced by activin.
Discussion
In the present study, we identify a mechanism whereby the Runx family of transcription factors potently regulates activin induction of FSH␤ gene expression. Our investigation confirms the expression of Runx2 in the pituitary gland of mice and focuses on the role of Runx2 as a potent repressor of activin action using a gonadotrope cell model. Promoter analyses show that RUNX2-mediated repression of activin induction is lost upon 5Ј truncation or cis mutation of any of the five previously characterized elements mutation of which causes a loss of activin induction, converting RUNX2 repression to induction of FSH␤ gene expression. Promoter truncations also reveal that in the absence of activin signaling, RUNX2 induces FSH␤ expression, an activity lost when region Ϫ194/Ϫ127 is deleted, thereby focusing our attention on the Ϫ159 Runx consensus site within the FSH␤ promoter. With regard to the mechanism of RUNX2-mediated transcriptional activity, these findings demonstrate that the effect of RUNX2 to induce or repress is closely tied to the highly coordinated and complex mechanism of activin action on the FSH␤ gene.
With regard to potential mechanisms of activin induction, Smad proteins are well-known signaling molecules activated by TGF␤ family members. Smad2 and Smad3 are phosphorylated by activin receptors at the plasma membrane and, together with Smad4, induce transcription of target genes (44) , including FSH␤ (9, 11, 12, 34) . Of importance to our investigation, Smad3 and Runx2 can physically and functionally interact at Runx composite elements (29, 30) and induce repression of the osteocalcin promoter (29, 30) , providing a potential mechanism whereby Runx2 could inhibit activin induction of FSH␤ gene expression. Consistent with this possibility, RUNX2 not only suppresses activin induction of FSH␤ but also represses induction by Smad3 as well. In actuality, RUNX2 nearly abolishes FSH␤ induction by Smad3 in comparison with the partial effect on activin induction (ϳ85% vs. ϳ50% reduced, Smad3 vs. activin, respectively; Fig. 7) , and mutation of the Runx2/Smad interaction domain eliminates Runx2-mediated repression of Smad3 induction. However, our finding that mutation of this domain only partially relieves repression of FSH␤ when it is induced by activin suggests that the mechanism of Runx2-mediated repression of activin induction likely involves multiple factors in addition to Smad3.
With regard to other mediators, recent evidence suggests that the forkhead transcription factor, FoxL2, another transcriptional regulator known to bind Smads (45) , is a critical mediator of activin induction of FSH␤ gene expression. Indeed, FoxL2 has been shown to bind the murine Ϫ106 activin response element (35) and has the potential to physically interact at the Ϫ153 site (46) . Thus, if FoxL2 is binding at Ϫ153, Runx2 could interfere with its action and interaction with Smads by binding at Ϫ159. Taken together, our results show that Runx2 action is dependent on the availability of Smad3 and other coregulatory proteins that interact at the Ϫ159 Runxbinding element and that the balance of these factors contribute to the direction in which Runx2 regulates the FSH␤ promoter.
Our findings reinforce the idea that Runx2 is a contextdependent transcription factor, functioning as either a corepressor or coactivator depending on formation of specific coregulatory protein interactions at the DNA level. These interactions are dictated by the carboxy terminus of (42), and Smad proteins (43) . Although our studies implicate the HTY Smad-interacting domain motif as important for Runx2-mediated repression of FSH␤, protein interactions via this domain are not necessary for the induction of LH␤ by Runx2. Furthermore, the idea that Runx2 can physically interact with a host of transcriptional effectors, which collectively dictate activation or repression, sheds light on our finding of induction of LH␤ as well as our observation that basal expression of FSH was induced, rather than repressed, when the FSH␤ promoter was rendered unresponsive to activin via cis mutation or 5Ј truncation. Again, these findings underscore the complexity of gene regulation by Runx2 and provide an intriguing and highly exciting mechanism of hormonal regulation of the gonadotropin genes. Developmentally, the importance of Runx2 cannot be underestimated because mice lacking Runx2 die immediately after birth due to the absence of mineralized bone (47) . In the reproductive axis, Runx2 is expressed within the ovary during the follicular to luteal phase transition of the ovulatory cycle and is important for luteinization of ovarian follicles (48, 49) . As for the pituitary gland, recent evidence suggests that RUNX2 is involved in human pituitary tumor formation (37) , and our findings confirm the presence of Runx2 in the mouse pituitary and the L␤T2 gonadotrope cell model. Although we did not detect changes in Runx2 mRNA across the ovulatory cycle in mice (unpublished observations) or observe protein levels of Runx2 within L␤T2 cells to change during hormone treatment, we cannot exclude the possibility that this tightly regulated transcription factor is altered by hormonal milieu within the gonadotrope cell itself. Another intriguing scenario is the potential interplay between the members of the Runx family. Indeed, all three Runx members are expressed in L␤T2 cells; however, we postulate that the protein interactions unique to Runx2 enable this regulatory factor to mediate specific regulatory effects upon the gonadotropin subunit genes.
In summary, our results demonstrate a novel role for Runx2 regulation of FSH␤ gene expression in gonadotrope cells. We identify a putative Runx binding site at Ϫ159 in the mouse FSH␤ gene and show that this site is necessary for RUNX2 repression of activin induction of FSH␤. Although RUNX2 also inhibits activin induction of ovine and human FSH␤, the mechanism of repression in these species may be indirect or through an element at another location. Collectively, this work has revealed new insights regarding hormonal regulation of the FSH␤ promoter by identifying a mechanism whereby FSH␤ expression is dampened after induction by activin.
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